Semenza, director of research at the New Jersey Gun Violence Research Center at the Rutgers School of Public Health, and co-authored by Christopher Thomas, an assistant professor at Rutgers University-Camden, was published June 17, 2026, in Criminology, the flagship peer-reviewed journal of the American Society of Criminology
Retatrutide is not licensed by the MHRA and is not available on NHS prescription in the UK
This is not a timing question
Available now in North Dakota, this FDA-approved weight loss medication is revolutionizing obesity treatment by mimicking hormones that naturally manage appetite and blood sugar
Whether you are exploring FDA-approved Zepbound treatment, compounded tirzepatide options, or other physician-guided weight loss programs, our goal is to help patients access safe, personalized care designed around their individual health goals